Taiwan FDA registration fb56eee5b427b1c81da55b9c161f2dbe

"Carneca" percutaneous puncture of the coronary ductus

TW: “卡內卡”經皮穿刺冠狀動脈導管
Taiwan flagTaiwan·Risk Class 2·KANEKA CORPORATION;; KANEKA CORPORATION OSAKA PLANT·Registered May 11, 2017 – May 11, 2027Active
Registration details
Analysis ID
fb56eee5b427b1c81da55b9c161f2dbe
Customs Code
DHA05602969802
Company information
Manufacturer Country
Japan
Authorized Representative
QUALTECH CONSULTING CORPORATION
Product details
Intended Use
For details, it is Chinese approved copy of the imitation order
Product Type (Level 1)
E Cardiovascular Medicine Science
Product Type (Level 2)
E.0005.
Import Information
import
Dates and status
Registration Date
May 11, 2017
Expiry Date
May 11, 2027
Companies making similar products

Top companies providing products similar to ""Carneca" percutaneous puncture of the coronary ductus"

Recent registrations

Recently registered similar products

About this record

Access comprehensive regulatory information for "Carneca" percutaneous puncture of the coronary ductus in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number fb56eee5b427b1c81da55b9c161f2dbe and manufactured by KANEKA CORPORATION;; KANEKA CORPORATION OSAKA PLANT. The authorized representative in Taiwan is QUALTECH CONSULTING CORPORATION.

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including KANEKA MEDIX CORPORATION KANAGAWA PLANT, and 1 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices1 Competitors1 Recent Registrations